Paloma Partners Management CO Teva Pharmaceutical Industries LTD Transaction History

Paloma Partners Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $187,137 - $254,788	14,643 New	14,643 $237,000
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $126,720 - $147,968	-12,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $132,352 - $163,968	12,800 New	12,800 $148,000
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $1.68 Million - $2.15 Million	-195,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $1.67 Million - $2.47 Million	195,000 New	195,000 $1.76 Million
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $128,138 - $210,358	-19,623 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $120,877 - $188,380	19,623 New	19,623 $135,000
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $142,205 - $241,863	-12,663 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $195,136 - $407,368	12,663	12,663 $223,000

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.